Bromide

Bromide

SCHEMBL20874281

CCOC(=O)C(N)CCC(=O)NC(CSC(=O)C[P+](c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)NCC(=O)OC.[Br-]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ GLO1 Q04760 4/20 0.43
▸ NOD1 Q9Y239 4/20 0.41
▸ TLR7 Q9NYK1 1/20 0.39
▸ CHRNB2 P17787 1/20 0.36
▸ CHRNB4 P30926 1/20 0.36
▸ CHRNA3 P32297 1/20 0.36
▸ CHRNA4 P43681 1/20 0.36
▸ PTGS1 P23219 1/20 0.35
▸ GSTK1 Q9Y2Q3 1/20 0.35
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ LTA4H P09960 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL20874163 0.96 GLO1 (0.46) GLO1NOD1TLR7CHRNB2CHRNB4
Bromide SCHEMBL20874207 0.94 GLO1 (0.45) GLO1NOD1TLR7CHRNB2CHRNB4
Bromide SCHEMBL20874330 0.94 TLR7 (0.42) GLO1TLR7PTGS1GSTK1CYP3A4
Bromide SCHEMBL20874346 0.93 GLO1 (0.42) GLO1NOD1TLR7CHRNB2CHRNB4
Bromide SCHEMBL20874309 0.93 GLO1 (0.45) GLO1NOD1TLR7CHRNB2CHRNB4
Bromide SCHEMBL20874193 0.93 GLO1 (0.42) GLO1NOD1TLR7CHRNB2CHRNB4
Bromide SCHEMBL20874322 0.90 GLO1 (0.47) GLO1NOD1CHRNB2CHRNB4CHRNA3
Bromide SCHEMBL20874255 0.89 GLO1 (0.45) GLO1NOD1CHRNB2CHRNB4CHRNA3
Bromide SCHEMBL20874367 0.88 GLO1 (0.44) GLO1NOD1TLR7CHRNB2CHRNB4
Bromide SCHEMBL20874215 0.88 GLO1 (0.41) GLO1TLR7PTGS1GSTK1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3468563-B1 COMPOUNDS FOR DELIVERING GLUTATHIONE TO A TARGET AND METHODS OF MAKING AND USING THE SAME UNIV OREGON STATE (US) 2023-09-13 — — EP disclosed
US-20190106456-A1 COMPOUNDS FOR DELIVERING GLUTATHIONE TO A TARGET AND METHODS OF MAKING AND USING THE SAME OREGON STATE UNIVERSITY (US) 2019-04-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190106456-A1 COMPOUNDS FOR DELIVERING GLUTATHIONE TO A TARGET AND METHODS OF MAKING AND USING THE SAME GSR, TXN2, GLS GLO1 106/4885NOD1 3585/4885TLR7 3908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback